LCD L36180: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease — Noridian
Policy LCD-L36180 · Hematology
New genetic testing guidelines announced by Noridian.
Code intelligence
C94.0 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C94.0.
Elevated code riskView ICD-10 detail
Signal breakdown
2 shown · 2 total in platform
Risk: Elevated
0
Critical
0%
1
High
50%
1
Routine
50%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L38176: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies — WPS
Policy LCD-L38176 · Oncology
New LCD affects billing for myeloid malignancy tests.
Audit documentation
Building an audit file that includes C94.0?
The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Hematology audit pack — $349One-time purchase · not a subscription